Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2012, Article ID 659016, 4 pages
http://dx.doi.org/10.1155/2012/659016
Case Report

Trisomy 11 as an Additional Chromosome Alteration in a Child with Acute Promyelocytic Leukemia with Poor Prognosis

1Faculty of Medical Sciences, State University of Rio de Janeiro, 20551-120 Rio de Janeiro, RJ, Brazil
2Bone Marrow Transplant Center, National Cancer Institute (INCA), 20551-120 Rio de Janeiro, RJ, Brazil
3Serviçio de Hematologia, Hospital Universitário Pedro Ernesto, Avenue 28 de Setembro no. 77, 3º andar, Vila Isabel, 20551-120 Rio de Janeiro, RJ, Brazil
4Hematology Service, HUCFF, UFRJ, 20551-120 Rio de Janeiro, RJ, Brazil
5Pronto Baby Children’s Hospital, 20551-120 Rio de Janeiro, RJ, Brazil

Received 14 February 2012; Accepted 11 June 2012

Academic Editors: P. D. Cotter, A. DeWan, B. Mittal, and A. M. Slavotinek

Copyright © 2012 Elenice Ferreira Bastos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Sanz, G. Martín, C. Rayón et al., “A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia,” Blood, vol. 94, no. 9, pp. 3015–3021, 1999. View at Google Scholar · View at Scopus
  2. S. De Botton, S. Chevret, M. Sanz et al., “Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial,” British Journal of Haematology, vol. 111, no. 3, pp. 801–806, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. L. G. Shaffer, M. L. Slovak, L. J. Campbell, and K. S. Basel, Eds., ISCN, 2009: An International System for Human Cytogenetic Nomenclature, 2009.
  4. D. Grimwade, H. Walker, F. Oliver et al., “The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial,” Blood, vol. 92, no. 7, pp. 2322–2333, 1998. View at Google Scholar · View at Scopus
  5. A. Cantu-Rajnoldi, A. Biondi, M. Jankovic et al., “Diagnosis and incidence of acute promyelocytic leukemia (FAB M3 and M3 variant) in childhood,” Blood, vol. 81, no. 8, pp. 2209–2210, 1993. View at Google Scholar · View at Scopus
  6. S. Li, L. Zhang, W. F. Kern et al., “Identification of t(15;17) and a segmental duplication of chromosome 11q23 in a patient with acute myeloblastic leukemia M2,” Cancer Genetics and Cytogenetics, vol. 138, no. 2, pp. 149–152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Mi, Y. Xue, W. Yu et al., “Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype,” Leukemia and Lymphoma, vol. 49, no. 3, pp. 524–530, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Mitelman, Catalog of Chromosome Aberrations in Cancer, Wiley-Liss, New York, NY, USA, 4th edition, 1991.
  9. L. Otero, B. Terra, C. Diniz, E. Abdelhay, and T. De Souza Fernandez, “Dicentric t(8;13)(q10;q10) as an additional chromosomal abnormality in a case of acute promyelocytic leukemia with very poor outcome,” Leukemia and Lymphoma, vol. 50, no. 2, pp. 287–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Pantic, A. Novak, D. Marisavljevic et al., “Additional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence,” Medical Oncology, vol. 17, no. 4, pp. 307–313, 2000. View at Google Scholar · View at Scopus
  11. M. L. Slovak, S. T. Traweek, C. L. Willman et al., “Trisomy 11: an association with stem/progenitor cell immunophenotype,” British Journal of Haematology, vol. 90, no. 2, pp. 266–273, 1995. View at Google Scholar · View at Scopus
  12. G. B. Zhou, J. Zhang, Z. Y. Wang, S. J. Chen, and Z. Chen, “Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy,” Philosophical Transactions of the Royal Society B, vol. 362, no. 1482, pp. 959–971, 2007. View at Publisher · View at Google Scholar · View at Scopus